Carole Ho, Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 5,536 shares at $23.79 ($132K) on 2023-08-14, disclosed to the SEC on 2023-08-16.
Scheduled sale ($132k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.79 | 2,768 | $66K | 50.0% |
| 2 | $23.79 | 2,768 | $66K | 50.0% |
| Total | $23.79 avg | 5,536 | $132K | 100% |
| Filing → |
| DNLI | SELL | 2024-08-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-15 | $107K | — | Filing → |
| DNLI | SELL | 2024-02-15 | $73K | — | Filing → |